Carregant...
Evaluation of Dosing Practices of Rivaroxaban and Dabigatran
Background: Anticoagulation is standard practice for the prevention and treatment of thromboembolic events. Two of the newer agents, rivaroxaban (Xarelto) and dabigatran (Pradaxa) are being utilized frequently in the inpatient and outpatient settings. Prescribers may not appreciate the need for dose...
Guardat en:
| Publicat a: | J Pharm Technol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5990184/ https://ncbi.nlm.nih.gov/pubmed/34860911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122514567923 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|